Tag: Ridgeback Biotherapeutics
Merck to launch antiviral pill, Molnupiravir, for Covid
Clinical trials on a new oral antiviral drug, Molnupiravir, from Merck and Ridgeback Biotherapeutics were stopped early because 'the results were so convincing' and...